Secondary Metabolites and Biotherapeutics

Dr. Awanish Kumar is an Associate Professor of the Department of Biotechnology at the National Institute of Technology, Raipur, Chhattisgarh, India. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery. Dr. Sunil Kumar is currently an Associate Professor at the Shri Ramswaroop Memorial University, Barabanki (Uttar Pradesh) India. His research interests include genetic engineering, molecular biology; medical microbiology particularly focused on molecular characterization of bacterial biofilm and drug development and inflammatory bowel diseases. Dr. Kumar has authored more than 40 peer-reviewed articles, 15 book chapters and edited one book for springer. Dr. Kumar serves as an editorial board member and reviewer of more than 6 international journals.

• 1. Secondary metabolites and its pharmacological application 　2. Ethnomedicinal bioactive secondary metabolites from wild underutilized plants 　3. Genetically modified plants for medicinal secondary metabolites production 　4. Bioprocessing: In-vitro approach for the mass production of bioactive secondary metabolites 　5. Metabolomics approach to find plant secondary  　6. Endophytes as a source of novel bioactive Secondary Metabolites 　7. Bioinformatics approach to facilitate identification of undiscovered pharmaceutically important secondary metabolites 　8. Role of Elicitors in production of medicinally important bioactive compound 　9. Pharmaceutical important secondary metabolites of bacteria 　10. Metabolome profiling of fungus for biotherapeutics 　11. Chronopharmacognosy and  secondary metabolites 　12. Nanotech: A tool to enhance bioactivity of secondary metabolites 　13.Secondary metabolites of plant as Anti- Quorum sensing compounds 　14. CRISPR-CAS for the production of secondary metabolites